WeedLife News Network
Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife Social Network.
A little genetic engineering, a lot of research, and a few metal tanks full of yeast bacteria could make mass-production possible.
The endogenous compound anandamide -- often referred to as the body's own marijuana -- plays a role in erasing memories of a traumatic event.
Six years after the idea was germinated, the nation’s first state-authorized medical marijuana research program is being launched in Philadelphia, state officials said.
UCLA chemists have reported the key chemical discovery necessary for the creation of a small, electronic marijuana breathalyzer.
Millions of people across the U.S. can legally buy pot at dispensaries — but scientists aren’t allowed to study it.
In an unusual turn, NIDA will pay researchers up to $100K per year to find out if smoking weed impacts COVID-19 symptoms.
Chemists at some of the biggest legal-weed companies are after an elusive prize: a predictable, reliable product.
A compound made by cannabis plants has been found to wipe out one of the most common drug-resistant bacteria in a study on mice, raising hopes of a new weapon in the fight against superbugs.
A newly discovered cannabis compound has been shown in the lab to potentially be 30 times more potent than THC, the most studied psychoactive compound in marijuana.
Hemp might prove more useful to bees than humans, and that’s saying a lot.
In 2019 a flavonoid of cannabis – Caflanone (FBL-03G) – was granted Orphan drug status by the United States Food and Drug Administration. Now, trials using the flavonoid to treat pancreatic cancer are anticipated to begin in the spring.
The director of the National Institute of Health explained that federal laws make it very hard to study marijuana in the U.S.
Before marijuana is ready for sale in Nevada dispensaries, it must first go through a laboratory screening process for a variety of pesticides and contaminants, as well as tests to determine potency levels.
Researchers accidentally proved that marijuana has the potential to ease the pain of capsaicin, which is the chemical responsible for putting the “hot” in hot peppers.
Arizona-based researcher Dr. Sue Sisley is spearheading an extraordinary lawsuit against the U.S. Drug Enforcement Administration (DEA), demanding that the agency stop dragging its feet on a years-old promise to end the federal government’s monopoly on growing cannabis for clinical research.
Imagine a pain reliever 30 times stronger at reducing inflammation than Aspirin. Researchers at the University of Guelph in Canada are the first to uncover the pain-relief potential of cannabis, demonstrating just how strong the plant could be.